// App-Quantinova.ai

: Waist-to-height ratio is a predictor of weight loss with Gelesis200 treatment for people with overweight or obesity having prediabetes or type 2 diabetes in the LIGHT-UP study

Researchers

Presenter

  • Livio Luzi

Principal Investigators

  • Sam Miller

  • Erika Matejkova

  • Barry McLean

  • Witold Zmuda

  • Pawel Bogdanski

  • Malgorzata Arciszewska

  • Anders Sjdin

  • Judith Salz

  • Anna Bochenek-Mularczyk

  • Lorena Lewy-Alterbaum

  • Michael Butcher

  • Gyorgy Paragh

  • Yvonne Davis

  • John Wilding

  • Howard Golub

  • Harry Leider

  • Yishai Zohar

  • Alessandro Sannino

  • Henry Calderon

  • Hassan Heshmati

Medical Centers

  • University of Milan, Milan, Italy

  • Pennington Biomedical Research Center Baton Rouge LA US Baton Rouge Louisiana United States

  • SAM Clinical Research Center, San Antonio, Texas, United States

  • Health & Care, sro, Prague, Czech Republic

  • Central Alabama Research, Birmingham, Alabama, United States

  • Medicome Sp. z o.o., Oswiecim, Poland

  • Poznan University of Medical Sciences, Poznan, Poland

  • NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny, Bialystok, Poland

  • University of Copenhagen, Frederiksberg, Denmark

  • Wake Research - Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States

  • Centrum Badawcze Wspolczesnej Terapii, Warszawa, Poland

  • ALL Medical Research, LLC, Cooper City, Florida, United States

  • Sterling Research Group, Ltd, Cincinnati, Ohio, United States

  • Oncology, Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary

  • Coastal Carolina Research Center, North Charleston, South Carolina, United States

  • Aintree University Hospital, Liverpool, United Kingdom

  • Clintara LLC, Boston, Massachusetts, United States

  • Analysis Group, Inc., Boston, MA, United States

Locations

  • Italy

  • United States

  • Czech Republic

  • Poland

  • Denmark

  • Hungary

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Prediabetes

  • Obesity

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • N/A

Study Id's

  • NCT03058029

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved